07:00 , Oct 31, 2011 |  BC Week In Review  |  Company News

Immunologix, Intrexon deal

Synthetic biology company Intrexon said it acquired Immunologix, which will become part of Intrexon's Protein Production Division. Immunologix's mAbLogix technology platform transforms naive B cells to produce human mAbs in vitro. Details were not disclosed....